X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14402) 14402
Publication (770) 770
Book Review (76) 76
Newsletter (51) 51
Book Chapter (25) 25
Conference Proceeding (18) 18
Magazine Article (8) 8
Book / eBook (5) 5
Dissertation (4) 4
Newspaper Article (4) 4
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8062) 8062
animals (7347) 7347
male (5643) 5643
female (4373) 4373
epoprostenol - pharmacology (3762) 3762
epoprostenol - biosynthesis (3045) 3045
rats (2897) 2897
prostacyclin (2610) 2610
adult (2272) 2272
epoprostenol - metabolism (2269) 2269
middle aged (1896) 1896
epoprostenol - therapeutic use (1802) 1802
in vitro techniques (1719) 1719
index medicus (1549) 1549
cells, cultured (1521) 1521
platelet aggregation - drug effects (1445) 1445
hypertension, pulmonary - drug therapy (1391) 1391
epoprostenol - analogs & derivatives (1310) 1310
epoprostenol - administration & dosage (1170) 1170
rabbits (1149) 1149
cardiac & cardiovascular systems (1131) 1131
epoprostenol (1121) 1121
dose-response relationship, drug (1113) 1113
pharmacology & pharmacy (1078) 1078
pulmonary hypertension (1023) 1023
aged (982) 982
dogs (982) 982
epoprostenol - physiology (974) 974
indomethacin - pharmacology (915) 915
blood pressure - drug effects (912) 912
epoprostenol - blood (902) 902
time factors (897) 897
endothelium, vascular - metabolism (872) 872
prostaglandins - pharmacology (870) 870
rats, inbred strains (846) 846
respiratory system (788) 788
pregnancy (756) 756
hypertension, pulmonary - physiopathology (743) 743
arachidonic acid (737) 737
prostaglandins - biosynthesis (736) 736
biochemistry & molecular biology (726) 726
blood platelets - metabolism (720) 720
blood platelets - drug effects (715) 715
antihypertensive agents - therapeutic use (709) 709
prostaglandins (706) 706
mice (702) 702
endothelium, vascular - drug effects (694) 694
peripheral vascular disease (687) 687
iloprost (665) 665
therapy (634) 634
nitric oxide (623) 623
arachidonic acids - metabolism (617) 617
aspirin - pharmacology (597) 597
hypertension (595) 595
cattle (579) 579
kinetics (571) 571
hemodynamics - drug effects (561) 561
survival (548) 548
platelet aggregation (538) 538
treatment outcome (537) 537
nitric-oxide (523) 523
endothelium (519) 519
prostaglandins e - pharmacology (518) 518
thromboxane a2 - biosynthesis (518) 518
muscle, smooth, vascular - drug effects (512) 512
surgery (494) 494
pulmonary arterial hypertension (489) 489
cyclic amp - metabolism (481) 481
antihypertensive agents - administration & dosage (465) 465
dinoprostone (464) 464
vasodilation - drug effects (452) 452
endothelium, vascular - cytology (449) 449
vasodilator agents - therapeutic use (447) 447
adolescent (445) 445
hematology (444) 444
aorta - metabolism (436) 436
nitric oxide - metabolism (430) 430
arachidonic acids - pharmacology (423) 423
medicine, general & internal (422) 422
rats, sprague-dawley (419) 419
physiology (414) 414
swine (413) 413
vasodilator agents - pharmacology (413) 413
6-ketoprostaglandin f1 alpha - blood (411) 411
6-ketoprostaglandin f1 alpha - metabolism (411) 411
prostaglandins - metabolism (409) 409
endocrinology & metabolism (406) 406
hypertension, pulmonary - etiology (404) 404
blood platelets - physiology (401) 401
muscle, smooth, vascular - metabolism (399) 399
vascular resistance - drug effects (396) 396
research article (391) 391
rats, wistar (386) 386
thromboxane a2 - metabolism (384) 384
platelet aggregation inhibitors - pharmacology (381) 381
hemodynamics (378) 378
cell biology (377) 377
prostaglandin-endoperoxide synthases - metabolism (376) 376
infusions, intravenous (372) 372
continuous intravenous epoprostenol (369) 369
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13143) 13143
Japanese (310) 310
German (218) 218
Russian (193) 193
French (154) 154
Chinese (123) 123
Polish (95) 95
Spanish (86) 86
Italian (61) 61
Hungarian (15) 15
Dutch (12) 12
Portuguese (11) 11
Turkish (10) 10
Czech (8) 8
Romanian (7) 7
Serbian (7) 7
Danish (6) 6
Swedish (6) 6
Finnish (5) 5
Slovak (5) 5
Hebrew (4) 4
Ukrainian (4) 4
Bulgarian (3) 3
Norwegian (3) 3
Korean (2) 2
Lithuanian (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 02/2003, Volume 44, Issue 2, pp. 271 - 279
Journal Article
Pharmacological Reviews, ISSN 0031-6997, 2012, Volume 64, Issue 3, pp. 540 - 582
Prostacyclin (PGI(2)) is a member of the prostanoid group of eicosanoids that regulate homeostasis, hemostasis, smooth muscle function and inflammation.... 
MIDDLE CEREBRAL-ARTERY | MESENTERIC RESISTANCE ARTERIES | PROSTANOID RECEPTORS | ENDOTHELIAL VASODILATOR PRODUCTION | FETAL DUCTUS-ARTERIOSUS | PROSTAGLANDIN I-2 | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | PERSISTENT PULMONARY-HYPERTENSION | SMOOTH-MUSCLE-CELLS | INTRAUTERINE GROWTH RESTRICTION | Adaptation, Physiological | Vascular Diseases - prevention & control | Cytochrome P-450 Enzyme Inhibitors | Epoprostenol - biosynthesis | Humans | Cytochrome P-450 Enzyme System - metabolism | Intramolecular Oxidoreductases - antagonists & inhibitors | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Endothelium, Vascular - drug effects | Endothelium, Vascular - enzymology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Pregnancy Complications, Cardiovascular - metabolism | Receptors, Epoprostenol - agonists | Pregnancy Complications, Cardiovascular - prevention & control | Enzyme Inhibitors - chemistry | Epoprostenol - pharmacology | Female | Intramolecular Oxidoreductases - metabolism | Infant, Newborn | Receptors, Epoprostenol - metabolism | Signal Transduction | Thromboxane-A Synthase - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Vascular Diseases - enzymology | Enzyme Inhibitors - therapeutic use | Pregnancy | Receptors, Epoprostenol - antagonists & inhibitors | Epoprostenol - analogs & derivatives | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Endothelium, Vascular - metabolism | Prostaglandin-Endoperoxide Synthases - metabolism | Thromboxane-A Synthase - metabolism | Ligands | Vasodilation - drug effects | Vascular Diseases - metabolism | Pregnancy Complications, Cardiovascular - enzymology | Review
Journal Article
Journal of Immunology, ISSN 0022-1767, 09/2016, Volume 197, Issue 5, pp. 1577 - 1586
Journal Article
Circulation, ISSN 0009-7322, 02/2013, Volume 127, Issue 5, pp. 624 - 633
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2017, Volume 363, Issue 3, pp. 348 - 357
This article describes the preclinical pharmacology and pharmacokinetics (PK) of hexadecyl-treprostinil (C16TR), a prodrug of treprostinil (TRE), formulated in... 
PROSTACYCLIN RECEPTOR | EP4 RECEPTOR | ANALOGS | ARTERIAL-HYPERTENSION | IP | PHARMACOLOGY & PHARMACY | BINDING | ILOPROST | Antihypertensive Agents - pharmacology | Nanoparticles - chemistry | Vasodilator Agents - pharmacokinetics | Phosphatidylethanolamines - adverse effects | Humans | Excipients - adverse effects | Male | Polyethylene Glycols - chemistry | Squalene - analogs & derivatives | Drug Compounding | Hypertension, Pulmonary - drug therapy | Epoprostenol - pharmacokinetics | Guinea Pigs | Squalene - adverse effects | Antihypertensive Agents - therapeutic use | Excipients - administration & dosage | Rats, Sprague-Dawley | Epoprostenol - analogs & derivatives | Lung - drug effects | Vasodilation - drug effects | Phosphatidylethanolamines - chemistry | Drug Delivery Systems - adverse effects | Epoprostenol - administration & dosage | Prodrugs - administration & dosage | Epoprostenol - metabolism | Vasodilator Agents - therapeutic use | Antihypertensive Agents - administration & dosage | Polyethylene Glycols - adverse effects | Hypertension, Pulmonary - blood | Nanoparticles - adverse effects | Dose-Response Relationship, Drug | Epoprostenol - therapeutic use | Excipients - chemistry | Epoprostenol - pharmacology | Female | Lung - metabolism | Platelet Aggregation - drug effects | Drug Evaluation, Preclinical | Squalene - chemistry | Vasodilator Agents - pharmacology | Administration, Inhalation | Phosphatidylethanolamines - administration & dosage | Squalene - administration & dosage | Antihypertensive Agents - pharmacokinetics | Polyethylene Glycols - administration & dosage | Animals | Prodrugs - pharmacokinetics | Dogs | Nanoparticles - administration & dosage | Prodrugs - therapeutic use | Lung - blood supply | Prodrugs - pharmacology | Vasodilator Agents - administration & dosage | Index Medicus
Journal Article
Science, ISSN 0036-8075, 12/2004, Volume 306, Issue 5703, pp. 1954 - 1957
Female gender affords relative protection from cardiovascular disease until the menopause. We report that estrogen acts on estrogen receptor subtype alpha to... 
SUPEROXIDE | CYCLOOXYGENASE-2 | ROLES | MULTIDISCIPLINARY SCIENCES | IN-VIVO | APOE-DEFICIENT MICE | NITRIC-OXIDE | ATHEROSCLEROSIS | RECEPTOR | THROMBOXANE A | 17-BETA-ESTRADIOL | Epoprostenol - metabolism | Muscle, Smooth, Vascular - metabolism | Oxidative Stress | Epoprostenol - biosynthesis | Antioxidants - metabolism | Cyclooxygenase 2 | Sulfones - adverse effects | Male | Sulfones - pharmacology | Lactones - pharmacology | Epoprostenol - physiology | Isoenzymes - metabolism | Receptors, Epoprostenol - physiology | Estrogen Receptor alpha - metabolism | Female | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Estradiol - pharmacology | Muscle, Smooth, Vascular - drug effects | Receptors, LDL - genetics | Ovariectomy | Mice, Inbred C57BL | Cells, Cultured | Hydrogen Peroxide - pharmacology | Lactones - adverse effects | Sex Characteristics | Cyclooxygenase Inhibitors - pharmacology | Mice, Knockout | Arteriosclerosis - prevention & control | Receptors, Epoprostenol - genetics | Animals | Cyclooxygenase 2 Inhibitors | Platelet Activation | Prostaglandin-Endoperoxide Synthases - metabolism | Arteriosclerosis - metabolism | Cardiovascular Diseases - chemically induced | Mice | Receptors, LDL - physiology | Lipid Peroxidation | Arteriosclerosis - pathology | Cyclooxygenase Inhibitors - adverse effects | Physiological aspects | Cardiovascular diseases | Research | Clinical trials | Cardiovascular disease | Females | Rodents | Menopause | Estrogen
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2003, Volume 41, Issue 12, pp. 2119 - 2125
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2013, Volume 32, Issue 5, pp. 546 - 552
Journal Article